Sep 28, 2020 1:00 PM ET
iCrowd Newswire – Sep 28, 2020
Zion Market Research has published a new report titled “Pharmaceutical Intermediates Market by Product Type (GMP and Non-GMP), by Applications (Antibiotics, Antipyretic analgesics, Vitamins, and Others), and by Distribution Channel (Direct Sales and Distributor): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2024”. According to the report, the global pharmaceutical intermediates market was valued at approximately USD 25,440 million in 2017 and is expected to generate revenue of around USD 33,608 million by end of 2024, growing at a CAGR of around 4.0% between 2018 and 2024.
Pharmaceutical intermediates are chemical compounds that form the building blocks of the active pharmaceutical ingredient (API). Pharmaceutical intermediates are produced as a by-product during the production of API. Every reaction in the production process of API gives rise to various different pharmaceutical intermediates. Pharmaceutical intermediates are used in the production of bulk drugs and also for research and development purposes by various pharma and biopharma companies.
One of the factors driving the growth of the pharmaceutical intermediates market over the forecast period is the increased burden of various diseases such as infectious diseases, chronic diseases, and others. This is expected to cause a surge in the demand for pharmaceutical intermediates over the forecast period. As per the Centers for Disease Control and Prevention 2017 report, there were around 16.8 million physician visits for infectious and parasitic diseases. Various research and development activities carried by pharmaceutical companies will further support the growth of the pharmaceutical intermediates market and help companies to expand their therapeutic area segment, which, in turn, will promote the growth of the pharmaceutical intermediate market. Furthermore, patent expiry is also a major factor supporting the growth of the pharmaceutical intermediate market. Moreover, high spending on research and development activities and constant demand for new and innovative therapies are expected to promote the growth of the pharmaceutical intermediates market over the forecast period. However, stringent regulatory policies are expected to slow down the growth of the pharmaceutical intermediates market in the coming years.
Get Free Report Sample for more Insights – https://www.zionmarketresearch.com/sample/pharmaceutical-intermediates-market
Pharmaceutical intermediates are classified on the basis of product type, application, and distribution channel. On the basis of product type, the pharmaceutical intermediates market is segmented into GMP and non-GMP. On the basis of application, the pharmaceutical intermediates market is segmented into antibiotics, antipyretic analgesics, vitamins, and others. On the basis of the distribution channel, pharmaceutical intermediates are segmented into direct sales and distributors.
Key regions of the pharmaceutical intermediates market are North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the pharmaceutical intermediate market over the forecast period due to the presence of developed countries such as the U.S. and Canada. Furthermore, the presence of various market players in the region coupled with the development of new products is projected to boost the market growth in this region. Europe is expected to be the second-largest growing region after North America. The Asia Pacific is expected to be the third-largest and fastest-growing region over the forecast period due to the presence of developing economies such as China and India. Also, a rise in the number of diseases has led to an increase in the demand for pharmaceutical intermediates in the Asia Pacific region. Latin America and the Middle East & Africa markets are expected to grow moderately, owing to the increased prevalence of diseases.
Browse full TOC of this Report – https://www.zionmarketresearch.com/toc/pharmaceutical-intermediates-market
Some of the major market players of the pharmaceutical intermediates market include A.R. Life Sciences Private Limited, Vertellus Holdings LLC, Lianhetech, Dishman Group, Midas Pharma GmbH, Codexis, Inc., Chemcon Specialty Chemicals Pvt. Ltd, Aceto Corporation, Cycle Pharma, Dextra Laboratories Ltd., BASF SE, Sanofi Winthrop Industrie S.A., ZCL Chemicals Ltd., and Easter Chemical Corporation, among others.
This report segments the global pharmaceutical intermediates market as follows:
Global Pharmaceutical Intermediates Market: Product Type Segment Analysis
Global Pharmaceutical Intermediates Market: Application Segment Analysis
- Antipyretic analgesics
Global Pharmaceutical Intermediates Market: Distribution Channel Segment Analysis
- Direct Sales
Global Pharmaceutical Intermediates Market: Regional Analysis
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
Browse Blog – https://healthcarenewsreports.com/
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: [email protected]
Keywords: Pharmaceutical Intermediates Market